Assessment of Rebound in Cancer Diagnoses in California in 2022, by Stage, Sociodemographic Factors, and Rurality

Authors

Institutions

Publication Details

Journal
Cancer Epidemiology Biomarkers & Prevention
Published
2025-12-17
DOI
https://doi.org/10.1158/1055-9965.epi-25-1246
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of Rebound in Cancer Diagnoses in California in 2022, by Stage, Sociodemographic Factors, and Rurality

Mindy C. DeRouen, Debora L. Oh, Katherine Lin, Erin L. Van Blarigan et al.
Cancer Epidemiology Biomarkers & Prevention
Global Cancer Incidence and Screening
article

Assessment of Rebound in Cancer Diagnoses in California in 2022, by Stage, Sociodemographic Factors, and Rurality

Mindy C. DeRouen, Debora L. Oh, Katherine Lin, Erin L. Van Blarigan, Iona C. Cheng, Salma Shariff‐Marco, Alison J. Canchola, Li Zhu, Scarlett Lin Gomez, Meg McKinley
article en

Abstract

No abstract available for this paper.
Cancer Epidemiology Biomarkers & PreventionVol. 35(3)
National Institutes of Health (US), University of California, San Francisco (US), National Institute of Nursing Research (US), National Cancer Institute (US), National Institutes of Health Clinical Center (US), University of San Francisco (US)
Openalex Percentile: Top 43%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.